Your browser doesn't support javascript.
loading
BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
Jia, Wei; Poe, Jonathan C; Su, Hsuan; Anand, Sarah; Matsushima, Glenn K; Rathmell, Jeffrey C; Maillard, Ivan; Radojcic, Vedran; Imai, Kazuhiro; Reyes, Nancy J; Cardona, Diana M; Li, Zhiguo; Suthers, Amy N; Curry-Chisolm, Itaevia M; DiCioccio, Rachel A; Saban, Daniel R; Chen, Benny J; Chao, Nelson J; Sarantopoulos, Stefanie.
Afiliação
  • Jia W; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.
  • Poe JC; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC.
  • Su H; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.
  • Anand S; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC.
  • Matsushima GK; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.
  • Rathmell JC; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC.
  • Maillard I; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.
  • Radojcic V; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC.
  • Imai K; Neuroscience Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Reyes NJ; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.
  • Cardona DM; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN.
  • Li Z; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Suthers AN; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; and.
  • Curry-Chisolm IM; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.
  • DiCioccio RA; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC.
  • Saban DR; Department of Ophthalmology.
  • Chen BJ; Department of Pathology, and.
  • Chao NJ; Biostatistics and Bioinformatics, Basic Science Department, Duke University Medical Center, Durham, NC.
  • Sarantopoulos S; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.
Blood ; 137(18): 2544-2557, 2021 05 06.
Article em En | MEDLINE | ID: mdl-33534893
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Transplante de Medula Óssea / Proteínas Proto-Oncogênicas c-bcr / Receptor Notch2 / Fator Ativador de Células B / Quinase Syk / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Transplante de Medula Óssea / Proteínas Proto-Oncogênicas c-bcr / Receptor Notch2 / Fator Ativador de Células B / Quinase Syk / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article